Valuation: Amedica Corporation

Market Cap 70.4L 60.9L 56.87L 52.17L 98.13L 67Cr 99.69L 6.67Cr 2.62Cr 34Cr 2.64Cr 2.59Cr 111.03Cr P/E 2026 *
-0.76x
P/E 2027 * -1.14x
Enterprise Value 70.4L 60.9L 56.87L 52.17L 98.13L 67Cr 99.69L 6.67Cr 2.62Cr 34Cr 2.64Cr 2.59Cr 111.03Cr EV / Sales 2026 *
3.06x
EV / Sales 2027 * 1.34x
Free-Float
75.59%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 63 01/12/2007
President - 16/03/2026
Director of Finance/CFO 41 04/09/2025
Director TitleAgeSince
Director/Board Member 63 01/12/2007
Director/Board Member 63 03/04/2025
Director/Board Member 72 05/11/2012
Change 5-day change 1-year change 3-year change Capi.($)
-7.92%-7.29% - - 70.4L
+0.47%+4.09%-9.92%+18.43% 13TCr
+1.37%-6.31%-16.79%-1.20% 1.24TCr
+5.28%+7.98%+104.57%+139.45% 1.01TCr
+2.59%-2.36%-42.76%-68.89% 458.08Cr
+2.93%+0.77%-14.62%+40.45% 262.04Cr
+2.16%+19.82%-21.92%-77.34% 170.25Cr
+2.82%+1.41%-14.77%-17.47% 163.99Cr
+2.16%+0.31%-30.10%-31.98% 162.57Cr
Average +1.29%+1.24%-5.79%+0.18% 2.05TCr
Weighted average by Cap. +0.65%-2.68%-4.77%+20.44%

Financials

2026 *2027 *
Net sales 23.04L 19.93L 18.61L 17.07L 32.11L 22Cr 32.62L 2.18Cr 85.69L 11Cr 86.5L 84.61L 36Cr 52.67L 45.56L 42.55L 39.03L 73.41L 50Cr 74.58L 4.99Cr 1.96Cr 25Cr 1.98Cr 1.93Cr 83Cr
Net income -1.24Cr -1.07Cr -99.99L -91.73L -1.73Cr -117.81Cr -1.75Cr -12Cr -4.6Cr -59Cr -4.65Cr -4.55Cr -195.21Cr -1.14Cr -98.41L -91.9L -84.3L -1.59Cr -108.27Cr -1.61Cr -11Cr -4.23Cr -54Cr -4.27Cr -4.18Cr -179.41Cr
Net Debt - -
Logo Amedica Corporation
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-